跳至主要内容
临床试验/CTRI/2023/01/049307
CTRI/2023/01/049307尚未招募未知

Effect of Olanzapine and Risperidone on clinical and biochemical profile of persons with Schizophrenia.

Government Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis of schizophrenia according to ICD-11
  • Drug naïve or not on any antipsychotic drug from past 4 weeks

排除标准

  • Patients with co-morbid substance dependence (except nicotine and caffeine)
  • Patients who are lactating or pregnant.
  • Patients with any unstable medical (hypothyroidism, diabetes insipidus, kidney disease, liver disease, chronic heart disease) neurological or surgical disorders.
  • Patients with history of active infection in last 2 weeks.
  • Patients with history of autoimmune diseases.
  • Patients on any immunosuppressant drug.
  • Acutely suicidal patients.

研究者

发起方
Government Medical College and Hospital

相似试验